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Background: There has been increased interest in the study of anaerobic bacteria that cause human
infection during the past decade. Many new genera and species have been described using 16S rRNA
gene sequencing of clinical isolates obtained from different infection sites with commercially available
special culture media to support the growth of anaerobes. Several systems, such as anaerobic pouches,
boxes, jars and chambers provide suitable anaerobic culture conditions to isolate even strict anaerobic
bacteria successfully from clinical specimens. Beside the classical, time-consuming identification
methods and automated biochemical tests, the use of matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry has revolutionized identification of even unusual and slow-growing an-
aerobes directly from culture plates, providing the possibility of providing timely information about
anaerobic infections.
Aims: The aim of this review article is to present methods for routine laboratories, which carry out
anaerobic diagnostics on different levels.
Sources: Relevant data from the literature mostly published during the last 7 years are encompassed and
discussed.
Content: The review involves topics on the anaerobes that are members of the commensal microbiota
and their role causing infection, the key requirements for collection and transport of specimens, pro-
cessing of specimens in the laboratory, incubation techniques, identification and antimicrobial suscep-
tibility testing of anaerobic bacteria. Advantages, drawbacks and specific benefits of the methods are
highlighted.
Implications: The present review aims to update and improve anaerobic microbiology in laboratories
with optimal conditions as well as encourage its routine implementation in laboratories with restricted
resources. E. Nagy, Clin Microbiol Infect 2018;▪:1
© 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.Introduction
Human pathogenic anaerobic bacteria were first discovered and
identified in the middle of the nineteenth century. However, it was
difficult at that time to obtain pure cultures for many of these or-
ganisms [1]. Even later, anaerobic infections were the most
commonly overlooked of all bacterial infections, especially whenl Microbiology, University of
E. Nagy).
biology and Infectious Diseases. Pu
t al., How to isolate, identify
and Infection (2018), https://the anaerobic bacteria were present in mixed culture and one or
more aerobic or facultative anaerobic pathogens were grown on the
same media at the same time. Use of insufficient anaerobic incu-
bation techniques will often permit only isolation of the most
common anaerobic pathogens, the members of the Bacteroides
fragilis group or Clostridium perfringens, which are known as
‘moderate’ anaerobes surviving oxygen levels up to 2%e8%. This
may let the microbiologist think that his/her techniques for
anaerobic culture are fully adequate, as they can regularly isolate
‘anaerobes’. It is difficult to provide a correct and practical defini-
tion of the term ‘anaerobe’. Anaerobic bacteria may differblished by Elsevier Ltd. All rights reserved.
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low oxygen levels are needed for them to multiply. A practical
definition was formulated by Professor Finegold in 1977: ‘anaerobe
is a bacterium that requires a reduced oxygen tension for growth
and fails to grow (form colonies) on the surface of solid media in
10% CO2, in air (18% oxygen)’ [1].
Various kinds of equipment to provide a suitable anaerobic
environment and different commercially available media for
culturing the wide range of anaerobic bacteria with different re-
quirements have been introduced into routine laboratories. The
application of 16S rRNA gene-sequencing-based identification for
difficult to identify anaerobes, and the matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-
TOF MS) for the direct identification of them from the primary
culture plate or from the anaerobic subculture plate, have made it
possible to provide accurate and timely information about their
role in infections. New anaerobic species have been detected and
identified through studies on the composition of the normal gut
microbiota, using a new culture tool called ‘culturomics’ [2,3]. All of
these achievements have increased the interest for anaerobes in
clinical situations and beyond. It has become increasingly impor-
tant in human medicine to identify anaerobic infections. One
reason is that there is a growing evidence of infections caused by
more virulent anaerobic species such as Clostridioides (Clostridium)
difficile PCR ribotype 027, which produces16-foldmore toxin than
classical strains [4], or Fusobacterium necrophorum causing some
cases of ‘culture-negative’ chronic tonsillitis [5], or enterotoxigenic
B. fragilis in sepsis and colon carcinoma [6,7]. Another reason is the
constant increase of immunocompromised patients such as pa-
tients with diabetic foot ulcers, which often involve neglected an-
aerobes [8,9]. Last, there are dynamic changes in antibioticFig. 1. Most common anaerobic species/groups of the commensal micro
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Bacteroides/Parabacteroides spp. to b-lactam/b-lactamase inhibitor
combinations, clindamycin and carbapenems, in Prevotella spp. to
b-lactams, in Gram-positive anaerobic cocci to clindamycin, and in
C. difficile and Bacteroides/Parabacteroides spp. to metronidazole
have been reported in Europe [10e12]. A special concern is metallo-
b-lactamase production in B. fragilis (Division II isolates) conferred
by the cfiA gene, whichmay lead to carbapenem resistance. In some
studies, the cfiA gene has been detected in nearly 40% of the
B. fragilis isolates [13]. Multidrug resistance has also been detected
among B. fragilis clinical isolates in different countries [14e16].
Surveillance studies about anaerobe culture techniques, identi-
fication and susceptibility testing methods carried out in routine
laboratories in theUSAand Belgiumhave shown that there are great
differences in the methods used in different laboratories, where
diagnostics other than detecting the presence of toxigenic C. difficile
in faeces is carried out in-house [17,18]. The aims of this review are
to discuss the presence of anaerobes in commensal microbiota and
in infectious processes, and to present optimal methodology for
carrying out anaerobic diagnostics of human infections.
Anaerobes as members of commensal microbiota and risks of
anaerobic infections
Anaerobes are abundant in commensal microbiota throughout
different body sites being the dominating or less dominating part of
the microbiota (Fig. 1) [3,19e21]. Low oxygen concentration in the
intestinal and urogenital tract favours the abundance of anaerobic
bacteria in these sites. In more aerated sites such as the oral cavity
and skin, the anaerobes inhabit protected sites where cohabiting
aerobic/facultative bacteria consume the oxygen [20]. This isbiome at different body sites. GPAC, Gram-positive anaerobic cocci.
and determine antimicrobial susceptibility of anaerobic bacteria in
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oured by damaged mucosal/cutaneous barriers, which allow their
penetration into normally sterile tissues often together with aero-
bic/facultative bacteria. Importantly, from most infections where
anaerobes are present together with aerobic/facultative bacteria, it
is difficult to isolate them in pure culture for identification. A great
variety of species belonging to strict anaerobic genera have been
proven to cause infections in almost all regions of the body andmay
lead to serious bloodstream infections as well (Table 1) [21,22].
Besides the well-known species, the spectrum of the anaerobic
bacteria isolated from infections in humans is increasing, due to
better isolation and identification possibilities. New anaerobic
genera and species have been shown to be present in serious in-
fections, such as the spore-forming, Gram-positive rod, Rob-
insoniella peoriensis, the non-spore-forming Gram-positive rods
Solobacterium moorei and Turicibacter sanguinis, Ruminococcus
gnavus or Oscillibacter ruminantium, causing bacteraemia and other
infections, just to mention a few examples [23e25].
Anaerobic microbiology is not routinely performed in many
laboratories because of technical and financial reasons. However,
the first steps for cost reduction depend on the clinicians' knowl-
edge of the characteristics of anaerobic infections and on laboratory
policy to reject unacceptable specimens such as those from body
sites containing anaerobic commensal microbiota (Table 2)
[18,19,21,26e28].
Key requirements for collection and transport of specimens
for anaerobic microbiology
To fully benefit from the anaerobic microbiology, clinicians
should collect and send clinical specimens to the laboratoryTable 1
Common detection rates of anaerobes in some clinically important infections [1,19e21,2
Prevalence of
anaerobesa
Very high (70%e100%) High (40%e70%)
Head and neck Most dental and oral infections,
involving head and neck cellulitis and
abscesses, root canal infections,
peritonsillar abscess, chronic sinusitis,
post-surgical infections
Chronic otitis media,
mastoiditis
Blood Intra-abdominal sepsis, septic abortion Bacteraemia after oral
surgery/tooth extraction
CNS Brain abscess, subdural empyema
Pulmonary Lung abscess, aspiration pneumonia,
necrotizing pneumonia, pleural
empyema
Skin/soft tissue Gas gangrene, breast abscess,
synergistic necrotizing cellulitis,
perianal and perirectal abscess, infected
diabetic gangrene, pilonidal abscess,
infections after trauma, acne vulgaris
Wound infections, absce
cellulitis, necrotizing fas
bite wound, diabetic foo
infection, infected
decubitus ulcers
Abdominal Most intra-abdominal infections,
appendicular abscess, appendicitis with
peritonitis, post-surgical abdominal
infections
Liver abscess
AAD Pseudomembranous colitis (Clostridium
difficile)
Bone/joint Orthopaedic device
infections
Urogenital Most female genital tract infections
(pelvic inflammatory disease, pelvic
abscesses, endometritis, vaginal cuff
abscess, bacterial vaginosis)
Abbreviations: AAD, antibiotic-associated diarrhoea; CNS, central nervous system; PJIs, p
a Detection rates vary according to the methods used.
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[19,21,26,27,29]. The specimens for anaerobe culture should be:
 collected at an appropriate timedbefore the start of antibiotic
therapy, or if this is not possible, just before the following drug
administration;
 collected at the infection sitede.g. for wound infections and
open abscesses, deep aspirates/tissue biopsies at the advancing
wound edge (where the bacteria multiply) rather than pus or
superficial specimens, and for closed abscesses, deep needle
aspirates of the lesion and close to the borders;
 aspirates and tissue biopsies instead of swabsdcotton wool
swabs are porous, prone to desiccation and contain inhibitory
fatty acidseit is best to use swabs made of synthetic fibres;
 free from contamination with commensal micro-
biotadtherefore, debridement and skin decontamination are
needed; sufficient volumes should be taken (e.g. 8e10 mL of
blood/bottle, >1e2 mL aspirates, 1 g tissues, 5 mL of watery/
semi-formed stool specimens for C. difficile);
 inserted in anaerobic transport media (ATMs)dthe best ATMs
are commercially available oxygen-free transport tubes/vials
with pre-reduced and anaerobically sterilized (PRAS) anaerobic
media, if not available, Stuart's, CaryeBlair or Amies transport
media can be prepared in the laboratory. Specimens should be
deeply inserted into the ATMs or onto the agar surface (after
ethanol cleaning of the ATM stopper) if PRAS ATMs are used and
the specimens are liquid;
 stored and transported at room temperature and not in a
refrigeratordat low temperatures, oxygen diffusion is increased;
 sent to the laboratory within 2 h in ATMsdalthough, if delay is
unavoidable, they can be accepted even after 8e48 h. If no ATMs6,28]
Moderate (13%e45%) Low (4%e10%) Very low (1%)
Ocular infections
(dacryocystitis, post-traumatic
endophthalmitis, perforated
corneal ulcers), cervical
lymphadenitis, serous otitis
media, tonsillopharyngitis
Acute sinusitis,
acute otitis media
Bacteraemia due
to endocarditis
CNS shunt
infections
Meningitis
Bronchiectasis, nosocomial
pneumonia,
sses,
ciitis,
t
Impetigo
Biliary tract infections, ascites
and hepatic abscess
Overall AAD (Clostridium
difficile and Clostridium
perfringens)
Osteomyelitis, infections
without orthopedic devices
PJIs
Urinary tract
infections
rosthetic joint infections.
and determine antimicrobial susceptibility of anaerobic bacteria in
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Table 2
Acceptable and unacceptable specimens for anaerobic microbiology [18,19,21,26,27,29,33]
Infection site Acceptable specimens Unacceptable specimens
Blood Blood (8e10 mL/bottle or acc. to the weight) in anaerobic blood bottles Catheter/catheter-tip
samples
Central nervous system Tissue biopsies or needle aspirates through intact decontaminated surface Surface swabs
Head and neck Percutaneous needle aspirates, surgical specimens. For Lemierre syndrome aspirates, tissue
biopsies. For actinomycosis sulphur granules as well
Oral, nose and throat swabs
except for Lemierre syndrome
Periodontal Abscess aspirates, subgingival pocket samples (by periodontal curettes or sterile paper points in
the canal)
Surface gingival and
oral swabs
Ear In otitis media: aspirates by tympanocentesis (with sterile micropipettes) Surface material
Eye Corneal scraping, vitreous fluid needle aspirates, conjunctival swabs As above
Abscesses Closed abscess: needle aspirates through intact decontaminated tissue, surgical samples;
fistulas/sinuses: deep plastic catheter aspirates after disinfected skin opening; open abscesses:
see Wounds
Skin/mucosal surface
swabs, pus
Pulmonary Pleural fluid, lung and transtracheal aspirates, lung-tissue biopsies, deep bronchial secretions
taken with double-lumen (protected) catheter
Nasopharyngeal
swabs, sputum
Abdominal cavity Peritoneal and ascites fluid aspirates, surgical biopsies, bile aspirates Ileostomy/colostomy
samples
Stool Only for Clostridium difficile or Clostridium botulinum For other anaerobes
Female genital tract Tissue biopsies, pelvic infection aspirates (by culdocentesis) peritoneal fluid, endometrial
specimens (by protected catheters), surgical specimens
Cervical/vaginal swabs
(except for bacterial vaginosis)
Bone Aspirate, bone biopsies. Taking several biopsies is recommended Swabs, soft-tissue samples
Joint, prosthetic joint Synovial fluid aspirates in anaerobic blood culture bottles, periprosthetic biopsies in anaerobic
broth media
Surface swabs of wounds/fistulas
Wounds/soft tissues Deep biopsy sampling, deep wound aspirates at the advancing wound edge after debridement
and cleaning the surface with sterile saline or alcohol
Surface swabs, pus, sinus tracts
Decubitus or skin ulcers Needle aspirates or tissue biopsies. Deep sampling from the base of lesion Surface material, swabs
Diabetic foot ulcers Bone biopsies (surgical or after debridement and surface disinfection) Tissue samples less suitable
Urine Bladder urine (suprapubic bladder aspirates) Voided and catheterized urine
E. Nagy et al. / Clinical Microbiology and Infection xxx (2018) 1e104are available, large volume (2 mL) aspirates should be placed
into sterile containers and in such cases, prompt transport
(within 1 h) is needed.
Processing specimens in the laboratory for culturing
anaerobes
All clinical microbiology laboratories that accept specimens for
anaerobic culture have to have facilities to isolate anaerobes and
screen for the major anaerobic groups (Level 1 and 2 anaerobic
laboratories) [21]. For definitive identification and antimicrobial
susceptibility testing (AST), isolated anaerobes should be referred
to reference laboratories. Level 3 anaerobic laboratories should
identify anaerobes to genus and species level using phenotypic
and enzymatic tests and should determine some presumptive
antibiotic sensitivity. Level 4 anaerobic laboratories should pro-
vide final identification using MALDI-TOF MS and, if needed, 16S
rRNA gene sequencing and should perform quantitative AST
[19,21].
After visual examination of the acceptable specimens (Table 2)
all samples should be homogenized in liquid medium (e.g. thio-
glycolate broth). Direct Gram-staining of the specimen is manda-
tory for anaerobic diagnostics [30]. It can reveal the presumptive
involvement of some anaerobic species with characteristic
morphology, such as Fusobacterium nucleatum, B. fragilis or
C. perfringens [19]. In the case of urinary tract infections, which
persist with negative aerobic culture growth, the rare uropathogen
Actinotignum (Actinobaculum) schaalii can be detected by Gram-
staining, indicating the need for prolonged incubation in CO2 or
inoculation on anaerobic media [31]. The direct Gram-staining also
makes it easy to distinguish between wound contamination
(showing abundance of squamous epithelial cells) and infection
(exhibiting both bacteria and inflammatory cells) [26]. Moreover,
the technique has shown higher sensitivity compared with culture
in the case of actinomycosis, where branching filamentous Gram-
positive rods may be observed in specimens from abscesses or si-
nus tracts [32].Please cite this article in press as: Nagy E, et al., How to isolate, identify
routine laboratories?, Clinical Microbiology and Infection (2018), https://The initial anaerobic culture process should include careful
plating on selective and non-selective blood agar plates (freshly
prepared in house or commercially available), as well as in liquid
anaerobic media (thioglycolate broth). The primary enriched (with
horse or sheep blood, vitamin K1 and haemin) non-selective media
should allow the growth of all clinically significant anaerobes.
Many laboratories in the USA prefer to use commercially available
PRAS media to isolate fastidious anaerobic pathogens [21]; how-
ever, homemade fresh anaerobic media can also be successfully
used. Based on the Gram-staining results of the specimen, further
selective media (Bacteroides bile esculin agar, kanamycine
vancomycin laked blood agar, phenylethyl alcohol agar, egg yolk
agar) can be inoculated [19]. If isolation of C. difficile is needed from
stool samples, the classical cycloserineecefoxitin fructose agar or
other commercially available selective chromogenic media should
be used [21,33]. Few laboratories process specimens in an anaerobic
chamber. Usually, work is performed outside an anaerobic envi-
ronment, but to limit oxygen exposure, it is important to place
inoculated media into an anaerobic environment (such as plastic
envelopes, boxes, jars, or automated gas flushing instruments, e.g.
Anoxomat or anaerobic chambers) within 15e20 min after inocu-
lation. Suggested incubation time is usually 48 h, but some anaer-
obes (such as C. perfringens) may form colonies earlier. Several
slow-growing anaerobes, however, may need much longer primary
incubation time (up to 3e5 days) to form colonies suitable for
subculturing or direct identification by the MALDI-TOF MS. The
anaerobic broth should be held for up to 14 days in special cases
such as detection of Cutibacterium spp. from prostatic joint in-
fections. Control of anaerobiosis during incubation is strongly rec-
ommended to be sure that even strict anaerobes will form colonies
[19,21,34].
Anaerobe incubation techniques
In routine laboratories, the classical Hungate role tube method
was rapidly replaced by the easier-to-use anaerobic jars, boxes,
pouches and chambers for isolation of anaerobic bacteria. Variousand determine antimicrobial susceptibility of anaerobic bacteria in
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tages [19,21]. The most expensive anaerobic chambers allow inoc-
ulation, inspection and subculturing in a permanent anaerobic
environment to ensure viability of fastidious, slow-growing an-
aerobes and to check the plates daily for growth. Anaerobic
pouches, boxes and jars need more organized specimen processing
as culture media are inoculated in air. Jars and boxes should not be
opened before 48 h of incubation to prevent premature death of
some slow-growing anaerobes by exposure to air during their
logarithmic growth phase. Today, automated gas flushing in-
struments (Anoxomat) can also be used to shorten the exposure of
inoculated plates to air because an anaerobic atmosphere can be
achievedwithinminutes [34,35]. If the clinical situation (symptoms
of gas gangrene) or initial Gram-staining result suggests the pres-
ence of C. perfringens, it may be prudent to incubate plates indi-
vidually in anaerobic pouches so that the plate may be examined
earlier. The reduced condition for any anaerobic system should be
monitored by the addition of anaerobe indicator strips (with
methylene blue or resazurin), which become colourless in the low
concentration of oxygen needed for appropriate growth of most
clinically important anaerobes. Cost-effective biological indicators
such as a subculture of Pseudomonas aeruginosa on Simmon's cit-
rate slant [19] or measuring the inhibition zone diameter of a 5-mg
metronidazole disc on an aerotolerant C. perfringens control strain
[34], can also be used.
To simplify anaerobe bacteriology, a medium containing
oxygen-removing enzymes such as oxyrase was recommended
[36]. OxyDish™ is a tightly sealed Petri dish with PRAS blood agar
medium containing the enzyme (OxyRase™) that removes oxygen
from the medium and the space above the agar after inoculation
and maintains anaerobic conditions during the incubation without
using anaerobic jars or chamber [36]. Another approach to elimi-
nate the use of anaerobic incubation systems is adding antioxidant
molecules such as ascorbic acid, glutathione and uric acid to the
blood agar plates (series of R mediumd‘quasi-universal’ media) to
avoid oxygen toxicity during incubation of the plates in ambient air
[37]. Both approaches may simplify laboratory procedures; how-
ever, a careful evaluation of their performance is needed for
isolation of strict anaerobic bacteria from specimens containing a
mixed bacterial population in clinical practice.
Identification of anaerobes
Initial examination of colonies should be performed using a
stereomicroscope or at least a strong magnifying glass. Colony
morphologies that appear similar when observed at a distance,
can be differentiated when magnified, and the presence of tiny
colonies near larger ones can be discerned. All different colonies
should be isolated and plated on an anaerobic blood agar plate, a
chocolate agar plate and a spot on a glass slide for Gram-staining.
Care should be taken that the same colony goes onto both plates
and the slide.
Classical identification of anaerobes was based on a series of
biochemical tests in PRAS test tubes with different sugars and
various other substrates incubated for 1e6 days depending on the
growth rate of the isolate. Careful evaluation of cell morphology
and detection of alcohol and short-chain fatty acids by gaseliquid
chromatography later became the basis of the identification of a
wide range of anaerobic bacteria [38]. Nowadays some routine
laboratories still rely on a presumptive identification carried out
after subculturing the colonies from the primary plate in an
anaerobic environment [19,21]. Beside investigation of colony and
Gram-stain morphology and motility, a combination of rapid
biochemical spot tests (such as detection of indole, catalase, nitrite,
urease positivity) and susceptibility to special potency antibioticPlease cite this article in press as: Nagy E, et al., How to isolate, identify
routine laboratories?, Clinical Microbiology and Infection (2018), https://discs such as kanamycin (1000 mg), vancomycin (5 mg) and colistin
(10 mg) can be used for the identification of major groups of an-
aerobes with clinical relevance. This presumptive identification is
cost-effective, but takes 24e48 h after isolation of the colonies on
the primary plate. Growth in the presence of 20% bile and the
pigmentation of the colonies (brown to black) of some Prevotella
and Porphyromonas spp. is characteristic after 4 days of incuba-
tion. Long-wave UV light can be used to detect characteristic fluo-
rescence of some colonies (e.g. C. difficiledchartreuse, Prevotella
melaninogenica, Porphyromonas asaccharolyticadbrick red) [19,21].
More detailed identification can be carried out by commercially
available manual or automated identification kits, using panels to
assess the ability of the isolated anaerobes to react with a limited
number of carbohydrates and other substrates after 24-h incuba-
tion in an anaerobic environment (detection of inducible enzymes).
Other systems detect preformed enzymes and the kits should be
incubated aerobically for 4e6 h; however, a high inoculum is
needed that is difficult to achieve in the case of slow-growing
anaerobic bacteria with tiny colonies. These systems are hindered
by a limited number of substrates to provide proper differentiation
for a wide range of anaerobic species; moreover, many anaerobic
bacteria are non-reactive in biochemical tests. Many clinically
important or newly described taxa may be lacking from the data-
bases. Users must be aware that databases of these products are
rarely updated [39,40].
Recently, MALDI-TOF MS based on soft ionization of large mol-
ecules such as proteins, peptides, lipids, sugars and DNA, has been
shown to perform very well for the identification of anaerobes
[41e43]. Microorganisms are identified by comparing their mass
spectrum with those of known reference strains. The initial cost of
the instrument may seem prohibitive to many microbiological
laboratories, but it is inexpensive to run and will identify anaer-
obes, as well as most other microorganisms, quickly and accurately.
As MALDI-TOF MS is a very sensitive method, only a very small
amount of biomass is needed for correct identification. This pro-
vides an early identification for anaerobes, very often directly from
the primary culture plates, without additional subculturing and
testing for aerotolerance. However, very small colonies frommixed
culture may need subculturing for a shorter or longer time before
MALDI-TOF MS identification. Applying the latest updates of the
databases associated with the twowidely used MS systems (Bruker
Biotyper - Bruker Daltonik, Germany, VITEK MS - bioMerieux,
France) is the prerequisite for the successful use of this technique.
The data libraries for anaerobes must include not only reference
strains, but also clinical strains corroborated by molecular
sequencing methods [42,44,45]. During the past few years, several
studies have proved the superiority of MALDI-TOF MS during
routine identification of anaerobes compared with different auto-
mated or manual biochemical identification kits [46e49]. Sample
preparation, incubation time, but not culture media or, in most
cases, exposure to oxygen can influence the quality of the identi-
fication of anaerobes by MALDI-TOF MS [50,51]. However, the MS-
based name of an isolate has to correlatewith the colony and Gram-
stain morphology. Further possibilities such as typing of anaerobic
bacteria (B. fragilis, C. difficile or Cutibacterium acnes) at the sub-
species level, determination of resistance and direct identification
of anaerobic blood culture isolates can also help in routine anaer-
obic diagnostics [42,52,53].
When the above-mentioned methods fail to correctly identify a
clinically important anaerobic strain to the genus or species level,
sequencing of genetic markers such as a portion of the 16S rRNA
gene or other genetic elements may be used for identification
[22,54]. Fig. 2 and Table 3 summarize the possibilities of species
identification of anaerobic bacteria with pros and cons including
the time needed for genus/species determination.and determine antimicrobial susceptibility of anaerobic bacteria in
doi.org/10.1016/j.cmi.2018.02.008
Fig. 2. Species identification of anaerobic bacteria by different methods and the minimum time needed.
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Resistance patterns of many anaerobes have changed signifi-
cantly over the last decades, both within and between countries.
This has made antimicrobial susceptibility of anaerobic bacteria
increasingly unpredictable [11,55]. There are specific infections
from which anaerobic isolates should be considered for AST
including bacteraemia, brain abscesses, endocarditis, osteomyelitis,
joint infections, infections of prosthetic devices and vascular grafts.
There are also some species of Clostridium, Bacteroides, Prevotella,Table 3
The available methods for species identification of anaerobic bacteria [19,21,38,40,42,43
Method Pros C
Wide range of biochemical
test in slants
Different substrates can be tested in PRAS
medium
T
re
Presumptive identification Easy to perform, flexible, early result is possible O
e
Manual identification kit with
24e48 h incubation
Easy to perform, small inoculum is enough A
g
Automated systems using
preformed enzymes kits
Timely result, easy to perform, no anaerobic
environment is needed
S
MALDI-TOF MS Rapid, reproducible, accurate identification,
cost effective to identify several isolates, little
biomass is needed, direct identification from
the primary plate without confirming
anaerobiosis, direct identification from positive
blood cultures
In
in
Sequencing Gold standard for species identification,
description of new species, decreasing cost and
time
S
Abbreviations: MALDI-TOF MS, matrix-assisted laser desorption/ionization time-of-fligh
Please cite this article in press as: Nagy E, et al., How to isolate, identify
routine laboratories?, Clinical Microbiology and Infection (2018), https://Fusobacterium, Bilophila and Sutterella, which are highly virulent
and have unpredictable susceptibility patterns. Persistence of se-
vere infection despite a proper antibiotic therapy is also a major
indication for the AST of anaerobic bacteria.
A methodology for easy, inexpensive and flexible routine AST of
anaerobic bacteria is not readily available, but is very much needed.
Some anaerobic bacteria are extremely sensitive to oxygen and the
impaired growth will often result in overcalling susceptibility. The
activity of metronidazole is also dependent on strict anaerobic
conditions and even small amounts of oxygen will greatly reduce]
ons Comments
ime consuming, labour intensive, subjective
ading
Classical method for
identification anaerobes
nly limited number of genera, species (~25
30) can be identified
If needed confirmation by more
developed method is possible
naerobe environment is needed, no time
ained till reporting
Limited database
pecial equipment is needed Limited database
itial cost is high, back up equipment is needed
high-throughput laboratories
Further developments in
progress to use it for typing and
antibiotic susceptibility testing
pecial knowledge and equipment are needed Molecular assessment
capability is needed
(bioinformatics)
t mass spectrometry; PRAS, pre-reduced and anaerobically sterilized.
and determine antimicrobial susceptibility of anaerobic bacteria in
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Table 4
The available methods for antimicrobial susceptibility testing of anaerobic bacteria [19,56,58,62]
Method Pros Cons Comment
Agar dilution Validated method. Cost effective if many
isolates are examined at the same time
Labour intensive Reference standard
Broth microdilution Commercial assays are available, multiple
antibiotics in one microtiter tray,
relatively inexpensive
Fixed antibiotics in commercial products,
medium labour intensive, only suitable
for the Bacteroides fragilis group
Limited number of studies on
commercial products
Gradient strips Easy and flexible, can detect
heteroresistance to some antibiotics
Expensive Concerns about performance and
warnings on specific agents
Disc diffusion Inexpensive, easy, flexible No validated method, studied mainly
fast-growing anaerobic species
EUCAST development project
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pseudo-resistance. The available methods for anaerobic AST
(Table 4) with pros and cons and for detection of special resistance
mechanisms are described below.
Agar dilution is considered as the reference standard for AST of
anaerobic bacteria. A comprehensive description of the standard
from the CLSI is available, with the most recent update from 2012
[56]. The method is most cost-effective if many isolates are exam-
ined at the same time (>100) and is the method for use when
carrying out surveillance studies (Fig. 3). For routine purposes, the
method is not practical for most laboratories. A modified version is
breakpoint testing with an agar containing the breakpoint con-
centration, i.e. no growth on the agar would categorize an isolate as
susceptible. This is a very rough estimate of susceptibility and does
not include intermediate susceptibility.
A standard broth dilution method, adapted for anaerobic bac-
teria with supplemented Brucella broth has been described by the
CLSI [56]. However, for several years a caveat has been included
which states: ‘Until further studies are performed to validate this
procedure for testing other organisms, it should be used only for
testing members of the B. fragilis group.’ [56]. There are commercial
micro-dilution trays with freeze-dried antibiotics available and
only the broth has to be added; however, some anaerobes such as
Gram-positive anaerobic cocci cannot grow well in broth. Very few
studies have evaluated the commercial broth micro-dilution sys-
tems for anaerobic bacteria including the B. fragilis group [57,58].
Gradient strips from several manufacturers are available for
anaerobic AST and are frequently used in routine clinical microbi-
ology laboratories. The standard medium for gradient strip AST
recommended by the manufacturer is the supplemented (vitamin
K1 and haemin) Brucella agar with 5% sheep blood. The most recent
and comprehensive evaluation of gradient strips from two different
manufacturers in comparison with agar dilution was published by
Rennie et al. in 2012 [59]. The study applied US Food and DrugFig. 3. Metronidazole susceptibility testing of Bacteroides fragilis group isolates by the agar
isolates were tested. One spot is free of growth lower right (negative control). From the top le
0.25 and 0.5 mg/L, respectively.
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standard and included amoxicillineclavulanate, imipenem,
metronidazole and penicillin. Overall none of the strips complied
with the FDA requirements for essential agreement (>90%) and the
rate of verymajor errors for metronidazolewas >10% for both strips
tested (FDA requirement <1.5%). In 2015, EUCAST issued a warning
concerning problems with piperacillinetazobactam gradient strips
from two manufacturers [60]. Gradient strips are the most conve-
nient AST method for most routine laboratories at the moment;
however, it is imperative that the method is performed strictly
according to the manufacturer's instructions and always include
the relevant quality control strains, e.g. B. fragilis ATCC 25285 and
C. difficile ATCC 700057.
Currently, neither EUCAST nor CLSI recommend the use of disc
diffusion for AST of anaerobic bacteria. Disc diffusion has been
investigated multiple times over the years with varying success,
possible reasons being incomplete standardization of all AST in-
gredients and conditions. For anaerobic bacteria, everything has to
be carefully standardized, including medium, inoculum, disc po-
tency, atmosphere (and this will vary depending on the method
used), temperature and time of incubation. Furthermore, anaerobic
bacteria have often been studied as one entity. However, they are
just as diverse a group of bacteria as all the aerobes. It is very un-
likely that one set of breakpoints across a wide range of anaerobic
species will perform reproducibly. A few recent attempts with disc
diffusion have been made with some success using EUCAST MIC
breakpoints for anaerobic bacteria. The studies have focused on a
single anaerobic species or group. In a study by Erikstrup et al., it
was possible to establish zone diameter breakpoints (ECOFFs) for
C. difficile for vancomycin (5 mg) and metronidazole (5 mg) [61]. The
study was performed in a standardized format using supplemented
Brucella blood agar. However, zone diameters were compared with
MICs from gradient strips and not by agar dilution. Nagy et al.
investigated the B. fragilis group using the same standardizeddilution method (the metronidazole concentration is shown below the plate). Twenty
ft to the right: the metronidazole MIC of isolates 7 and 14 can be read from the plates as
and determine antimicrobial susceptibility of anaerobic bacteria in
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Table 5
Laboratory procedures for anaerobe bacteriology according to the cost effectiveness [19,21]
Cost effective Costly (optimal)
Transport of the specimen In home-made anaerobe transport media,
sterile specimen container
In PRAS anaerobic transport media in tube or vial
Primary plates Home-made fresh media Commercially available supplemented anaerobe media, PRAS media
Incubation Anaerobic pouches, jars, boxes Anoxomat jar system, anaerobic chamber
Identification Presumptive identification using Gram stain, special antibiotic
potency discs, spot indole, urease, catalase tests, rapid ID strips
MALDI-TOF MS, if needed 16S rRNA gene sequencing
AST Not done, suggestion for therapy according to
published surveillance data, b-lactamase test
Gradient test, broth micro-dilution test
For surveillance agar-dilution test
Abbreviations: AST, antimicrobial susceptibility testing; MALDI-TOF MS, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; PRAS, pre-reduced and
anaerobically sterilized.
E. Nagy et al. / Clinical Microbiology and Infection xxx (2018) 1e108format of disc diffusion in comparison with agar dilution [62]. For
imipenem (10 mg), metronidazole (5 mg) and clindamycin (10 mg)
there was very good zone diameter separation between susceptible
and resistant isolates, but for piperacillinetazobactam (30/6 mg)
this was not the case with many intermediately susceptible isolates
among the susceptible. EUCAST is currently working on the
development of a disc diffusion method for anaerobic bacteria,
which will grow on a special rich mediumwith an incubation time
of 24e48 h in an anaerobic environment (personal communication
from EUCAST Development Laboratory, V€axj€o, Sweden).
The use of antioxidants (1 mg/mL ascorbic acid and 0.1 mg/mL
glutathione) in the Schaedler agar medium was tested as an easy
method for metronidazole MIC determination of five anaerobic
culture collection strains incubated in an aerobic atmosphere for
72 h [63]. The long incubation time used and the lack of further
publications comparing the data obtained with this method with
those by the CLSI standard agar dilution method with anaerobic
incubation, are however limitations of its applicability in routine
practice.
Apart frommethods that categorize isolates as S, I or R, different
methods for detection of specific resistance mechanisms are also
available, although the clinical implications are not always clear. b-
lactamase disc testing including a chromogenic cephalosporin is
mentioned in many guidelines, but is probably of limited value
[19,56]. It is performed in the sameway as with aerobic bacteria but
the reaction might be slower (up to 30 min). If positive, the isolates
should be considered resistant towards penicillin and ampicillin/
amoxicillin. A negative test does not rule out penicillin or ampi-
cillin/amoxicillin resistance and an MIC test should be performed.
Double gradient strips with meropenem ± EDTA can be used to
detect metallo-b-lactamase production in B. fragilis, although this
does not always result in R categorization according to MIC
breakpoints. Schwensen et al. detected metallo-b-lactamase pro-
duction in B. fragilis isolates with meropenem MICs as low as
0.5 mg/L, which is below the EUCAST clinical MIC breakpoint of
2 mg/L [64]. The clinical implications of low-level metallo-b-lac-
tamase production are not known. However, single mutations
resulting in high-level resistance have been described, i.e. the
presence of the cfiA gene and/or low-level metallo-b-lactamase
production could be considered a warning [14,16]. Table 5 sum-
marizes laboratory procedures including the specimen trans-
portation, isolation, identification and antimicrobial susceptibility
testing for different laboratories providing diagnosis of anaerobic
infections according to the estimated cost.
Conclusions
With increasing knowledge on the wide variety of anaerobic
bacteria living together with humans and potentially causing
serious infections, the anaerobic bacteriology in routine labora-
tories is becoming more and more challenging. ThesePlease cite this article in press as: Nagy E, et al., How to isolate, identify
routine laboratories?, Clinical Microbiology and Infection (2018), https://microorganisms are sensitive to different oxygen levels, therefore,
if wewant to be sure that all possible pathogenic anaerobic bacteria
will form colonies on the surface of the primary plates, we have to
provide excellent culture conditions includingmedia and anaerobic
environment. The diagnostic process however, also has to differ-
entiate infecting pathogens from those that are often just present as
members of the commensal microbiota on mucosal surfaces. The
clinicians' role is crucial in this process, besides considering an-
aerobes in many infections; they have to take samples very care-
fully, preventing contamination with commensal microbiota. The
application of advanced DNA-based and protein-based diagnostic
methods to identify known anaerobic species or to detect new
genera or species, create the need for taxonomic changes. The
question is how the many new names of earlier known anaerobes
such as Clostridioides (Clostridium) difficile or Cutibacterium (Pro-
pionibacterium) acnes and those which were recently described as
pathogens isolated from normally sterile body sites (such as Bac-
teroides dorei, Oscillibacter ruminantium, Robinsoniella peoriensis,
Ruminococcus gnavus, Sneathia sanguinegens, Solobacterium moorei,
Turicibacter sanguinis, etc.) will be accepted by the clinically ori-
ented scientists.
Institutions have to allocate resources to their routine microbi-
ology laboratories to develop expertise and practice to work with
anaerobes and to be able to select the suitable laboratory procedures
to give timely anduseful reports to the clinicians. The laboratory staff
has to determine the level of the anaerobic bacteriology theywill use
and also needs to carry out a risk assessment of the consequences.
The financial situation will determine what kind of transport sys-
tems,media, incubation facilities and identificationprocesses should
be used to reduce potential patient harm as much as possible by
neglected anaerobic infections. The ESCMID Study Group for
Anaerobic Infections (ESGAI) is regularly organizing postgraduate
technical workshops to provide knowledge and help for those who
want to improve their service for clinicians in this field.
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